this comment shows how little you understand about the a2m product. if you dont have your health, you wont be around to benefit from "revolutionary" tech companies. i was referring to APT - they are not revolutionary. this is demonstrated by the fact that they are not profitable and are being copied by anyone who can create an app and has funding to create an installment payment system.
a2m has IP and r&d. a2m funds studies into the effects of a1 protein. how is a2 not revolutionary?
Results factured in or not, page-17
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12501 | $6.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.88 | 33092 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |